Fortress Biotech (NASDAQ:FBIO) just reported results for the second quarter of 2024.
- Fortress Biotech reported earnings per share of -73 cents. This was above the analyst estimate for EPS of -$1.23.
- The company reported revenue of $14.90 million.
- This was 0.83% better than the analyst estimate for revenue of $14.77 million.